Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anika Therapeutics Inc. - Common Stock
(NQ:
ANIK
)
16.31
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6
Open
16.31
Bid (Size)
12.90 (2)
Ask (Size)
20.00 (3)
Prev. Close
16.31
Today's Range
16.31 - 16.31
52wk Range
15.82 - 29.11
Shares Outstanding
14,828,456
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Anika To Participate in December 2024 Investor Conferences
November 22, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
Via
Benzinga
Performance
YTD
-28.02%
-28.02%
1 Month
-3.89%
-3.89%
3 Month
-34.81%
-34.81%
6 Month
-37.08%
-37.08%
1 Year
-28.46%
-28.46%
More News
Read More
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 31, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
What's Next: Anika Therapeutics's Earnings Preview
October 30, 2024
Via
Benzinga
Anika Therapeutics: Q4 Earnings Insights
March 13, 2024
Via
Benzinga
Earnings Outlook For Anika Therapeutics
March 12, 2024
Via
Benzinga
Anika Announces Third Quarter 2024 Results Conference Call Date
October 17, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 15, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Via
ACCESSWIRE
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Anika to Participate in the Sidoti Virtual Investor Conference
August 05, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 25, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 11, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
May 29, 2024
Via
Benzinga
Anika Enters into Cooperation Agreement with Caligan Partners
May 28, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Earnings Scheduled For March 13, 2024
March 13, 2024
Via
Benzinga
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 08, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.